CA
ACLX

CoreCap Advisors’s Arcellx ACLX Stock Holding History

CoreCap Advisors’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19
Closed -$1.46K – 3139
2024
Q4 		$1.46K Buy
+19
New +$1.64K ﹤0.01% 2302

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

CoreCap Advisors's ACLX Position: Q1 2025 in Review

CoreCap Advisors sold out of Arcellx (ACLX) in Q1 2025, closing a stake of 19 shares — an estimated $1.46K sold.

CoreCap Advisors first reported a position in ACLX in Q4 2024 and held it in 1 quarter. The position peaked at $1.46K in Q4 2024. 197 funds tracked by Wall St. Rank hold ACLX as of Q1 2025.

  • CoreCap Advisors reported no remaining Arcellx position as of Q1 2025 after selling out during the quarter.
  • CoreCap Advisors sold 19 Arcellx shares in Q1 2025, an estimated $1.46K.
  • CoreCap Advisors first reported a position in Arcellx in Q4 2024 and held it in 1 quarter.
  • CoreCap Advisors's Arcellx position peaked at $1.46K in Q4 2024.
  • 197 funds tracked by Wall St. Rank held Arcellx as of Q1 2025.

Based on CoreCap Advisors's 13F filing for Q1 2025, filed 9 May 2025.